People often ask us what roles Natural Language Processing (NLP) can play in health settings. It is relatively easy to rattle off half a dozen examples of cases studies. However, these instances don’t fulfil the need of enquirers who are really looking to understand the scope of the technology to weigh it up against their […]
We have recently assessed the accuracy of Clinical NLP software available through either open source projects or commercial demonstration systems at processing pathology reports. This whitepaper discusses the twenty-eight deficiencies we observed in our testing of five different systems.
Health Language Analytics has passed an acceptance test for automating the document classification and coding processes of the California Cancer Registry (CCR), and its Horizon technology is now scheduled to be part of the next CCR production release in January. The global arm of Sydney-based natural language processing firm Health Language Analytics, HLA has been […]
Press Release: Australia’s HORIZON Machine Learning Platform in Deal to Crunch Data for the California Cancer Registry HORIZON has been chosen by California’s Public Health Institute (PHI) to extract and codify cancer data from pathology text reports for The California Cancer Registry (CCR) program. HORIZON platform will deliver a rich data set that can be […]
Ying Ou and Professor Jon Patrick’s manuscript entitled “Automatic negation detection in narrative pathology reports” has been accepted for publication in Artificial Intelligence in Medicine. Abstract Objective To detect negations of medical entities in free-text pathology reports with different approaches, and evaluate their performances. Methods and material Three different app...
Press Release iCIMS and HLA today are excited to announce the formation of a joint Advisory Board, which includes highly experienced executives from the Health and IT sectors, and the Government. The board members are: Professor David G. Penington AO, John DeBrincat, and Denis Tebbutt. Their brief biographies can be viewed on our website. Professor […]
HLA has been proudly chosen as one of the 25 early stage startups of the week from around the world to exhibit for free as part of the Alpha Program at Web Summit 2014. The event runs from 4-6 Nov 2014 at RDS, Dublin, Ireland. See you there!
HLA and sister company iCIMS have joined forces with researchers at the University of the Basque Country and the Department of Health of the Basque government, Osakidetza, for a unique project. The aim is for Basque speaking doctors to write their clinical records in Basque and then have basic information such as clinical history and […]
HLA has been awarded a $50,000 grant from Commercialisation Australia to identify better its market, and develop its marketing skills and business planning. The CEO, Professor Jon Patrick has welcomed the faith that Commercialisation Australia have put into the company given the extraordinarily complex task it is engaged in building a business around the analysis […]
A review of our project with the Victorian and NSW Cancer Registries has just been provided to us by Cancer Australia. Here are some of the assessments: The final version of the case ascertainment classifier successfully achieved the revised target for sensitivity of 99%, and the initial target for specificity of 96%, to correctly identify […]